| # | Country | Total Patents | |
|---|---|---|---|
| #1 | WIPO (World Intellectual Property Organization) | 6 | |
| #2 | EPO (European Patent Office) | 5 | |
| #3 | United States | 4 | |
| #4 | Japan | 2 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement |
| # | Technology | |
|---|---|---|
| #1 | Peptides | |
| #2 | Medical preparations | |
| #3 | Therapeutic chemical compounds | |
| #4 | Analysing materials | |
| #5 | Microorganisms | |
| #6 | Fermentation |
| # | Name | Total Patents |
|---|---|---|
| #1 | Bensussan Armand | 12 |
| #2 | Alberici Gilles | 12 |
| #3 | Bonnefoy Nathalie | 11 |
| #4 | Bastid Jeremy | 9 |
| #5 | Eliaou Jean-Francois | 8 |
| #6 | Bastid Jérémy | 6 |
| #7 | Eliaou Jean-François | 5 |
| #8 | Bonnefoy-Berard Nathalie | 4 |
| #9 | Jean-Francois Eliaou | 2 |
| #10 | Jeremy Bastid | 2 |
| Publication | Filing date | Title |
|---|---|---|
| WO2021023624A1 | Novel il-17b antibodies | |
| WO2020201442A1 | Combination therapies based on pd1 and il-17b inhibitors | |
| EP2864355A1 | Il-17 antagonist antibodies | |
| WO2013186236A1 | Antagonists of il-17 isoforms and their uses | |
| EP2858670A1 | Antagonists of il-17 isoforms and their uses | |
| EP2654789A1 | Antibodies against human cd39 and use thereof | |
| EP2569335A2 | Methods of treating and/or preventing cell proliferation disorders with il-17 antagonists |